2 results

• ExplainedHow can a medicine change what supermarkets sell?GLP-1 medicines reduce appetite and food intake for many users. At population scale, that can alter portion sizes, snacking frequency and the types of foods companies choose to develop, even though the medicines are not food products themselves.
• MoneyWeight-loss drugs are becoming a snack-company problem.PepsiCo is already fighting inflation, weak snack volumes and investor pressure. GLP-1 drugs add a more structural question: what happens to a food business built around frequent snacking when some customers feel less hungry?